alexa Sevoflurane Pretreatment Reduces High Glucose-induced Oxidative Stress And Inflammatory Injury In Human Umbilical Vein Endothelial Cells | 24886
ISSN: 2155-6156

Journal of Diabetes & Metabolism
Open Access

Like us on:

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

5th World Congress on Diabetes & Metabolism

Suobei Li
ScientificTracks Abstracts: J Diabetes Metab
DOI: 10.4172/2155-6156.S1.026
Abstract
Background: Hyperglycemia induced oxidative stress and inflammatory injury result in endothelial dysfunction, which is a risk factor for cardiovascular disease. Sevoflurane, one of the most commonly used volatile anesthetics, has been proven to be effective in combating oxidative stress and protecting organs against inflammatory injury in various conditions. We hypothesized that sevoflurane pretreatment could protect endothelial cells against high glucose-induced endothelial dysfunction, and that the protective effects of sevoflurane preconditioning might be associated with the reduction of inflammatory cytokines. Methods: Primary cultured human umbilical vein endothelial cells (HUVECs) were exposed to sevoflurane (0.5, 1.5 and 2.5 minimum alveolar concentration, MAC) for 30 min with or without N(G)-nitro-L-arginine methyl ester (L-NAME, a nitric oxide synthase inhibitor) 1 mMfor 1 hour, and then incubated with high glucose (HG, 25 mM) for 12 hours, respectively. Tumor necrosis factor-α(TNF-α) release in culture medium was detected by using ELISA. Expression of intracellular adhesion molecule-1 (ICAM-1) and vascular cell adhesion molecule-1 (VCAM-1) (cell ELISA and Western blot) and activation of NF- κB (Western blot) were also assessed. Adhesion of HRP-labeledHL-60 to HUVECs was measured by a spectrophotometer. The intracellular reactive oxygen species (ROS) production was assessed by monitoring the DCF fluorescence level after incubation with 25 mM glucose for 1 hour. Results: In our study, the high glucose-induced increases in TNF-α release and expression of ICAM-1 and VCAM-1 were significantly attenuated by pretreatment with sevoflurane in a dose-dependent manner in cultured HUVECs. Enhanced cell adhesion caused by high glucose in co-cultured HL-60 and HUVEC was also blocked by pretreatment with sevoflurane. Pretreatment with sevoflurane also blocked formation of high glucose-induced ROS in HUVECs. In addition, sevoflurane suppressed the transcriptional activity of NF-κB and IκB phosphorylation under high glucose conditions. Pretreatment with L-NAME attenuated the protective action of sevoflurane on high glucose-induced ICAM-1 and VCAM-1 expression, activation of NF-κB and leukocytes adhesion to HUVECsαsuggesting a potential role of nitric oxide (NO) signaling. Conclusion: The present data suggest that sevoflurane could suppress high glucose-induced oxidative stress and vascular inflammatory processes, and sevoflurane confers cytoprotective effects likely through inhibition of ROS and NF-κB activation in aNO-dependent manner in HUVECs.
image PDF   |   image HTML
 

Relevant Topics

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2018-19
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri & Aquaculture Journals

Dr. Krish

[email protected]

+1-702-714-7001Extn: 9040

Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

[email protected]

1-702-714-7001Extn: 9042

Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001Extn: 9040

Clinical Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

Food & Nutrition Journals

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

General Science

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics & Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Materials Science Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Nursing & Health Care Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

Ann Jose

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001Extn: 9042

 
© 2008- 2018 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
Leave Your Message 24x7